Current Clinical Studies

Artificial Intelligence: CURATE.AI

CURATE.AI: ST-UO

N.1 Labs is currently conducting a prospective, first-in-human interventional study pertaining to CURATE.AI-driven optimisation of solid tumor combination therapy (metastatic/advanced). This is a N-of-1 clinical trial and is not currently recruiting additional patients.

Results for this study are pending. 

 

CURATE.AI: ST-HCC

N.1 Labs is currently conducting a prospective, first-in-human interventional study pertaining to CURATE.AI-driven optimisation of solid tumor combination therapy (metastatic/advanced). This is a N-of-1 clinical trial and is not currently recruiting additional patients.

 

CURATE.AI: TM-L

N:1 Labs is currently conducting a prospective interventional study pertaining to CURATE.AI-driven optimisation of post-transplant immunosuppression. This is a N-of-1 clinical trial and patient recruitment is pending (Clinicaltrials.gov: NCT03527238)

Results from the first-in-human study can be found in Science Translational Medicine, 333ra49, 2016 http://stm.sciencemag.org/content/8/333/333ra49 

Nanomedicine

NDGP (Nano 1)

We have received approval to initiate clinical studies to validate Nanodiamond-Gutta Percha (NDGP) as a non-surgical root canal biomaterial (Clinicaltrials.gov: NCT02698163).

Results from the first-in-human study can be found in PNAS, E9445, 2017 http://www.pnas.org/content/114/45/E9445

GPx (Nano 2)

We have received approval to initiate clinical studies to validate a therapeutic-Nanodiamond-GP (GPx) device (Clinicaltrials.gov: NCT03376984).